CNOT2
CCR4-NOT transcription complex subunit 2
Also known as: CDC36, CNOT2_HUMAN, NOT2, NOT2H
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NZN8
- Gene
- CNOT2
- Ensembl
- ENSG00000111596
- Chromosome
- 12
- Canonical length
- 540 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes a subunit of the multi-component CCR4-NOT complex. The CCR4-NOT complex regulates mRNA synthesis and degradation and is also thought to be involved in mRNA splicing, transport and localization. The encoded protein interacts with histone deacetylases and functions as a repressor of polymerase II transcription. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Dec 2010]
Canonical amino-acid sequenceUniProt
540 residues, UniProt reviewed canonical sequence.
>Q9NZN8|CNOT2
1 MVRTDGHTLS EKRNYQVTNS MFGASRKKFV EGVDSDYHDE NMYYSQSSMF PHRSEKDMLA
61 SPSTSGQLSQ FGASLYGQQS ALGLPMRGMS NNTPQLNRSL SQGTQLPSHV TPTTGVPTMS
121 LHTPPSPSRG ILPMNPRNMM NHSQVGQGIG IPSRTNSMSS SGLGSPNRSS PSIICMPKQQ
181 PSRQPFTVNS MSGFGMNRNQ AFGMNNSLSS NIFNGTDGSE NVTGLDLSDF PALADRNRRE
241 GSGNPTPLIN PLAGRAPYVG MVTKPANEQS QDFSIHNEDF PALPGSSYKD PTSSNDDSKS
301 NLNTSGKTTS STDGPKFPGD KSSTTQNNNQ QKKGIQVLPD GRVTNIPQGM VTDQFGMIGL
361 LTFIRAAETD PGMVHLALGS DLTTLGLNLN SPENLYPKFA SPWASSPCRP QDIDFHVPSE
421 YLTNIHIRDK LAAIKLGRYG EDLLFYLYYM NGGDVLQLLA AVELFNRDWR YHKEERVWIT
481 RAPGMEPTMK TNTYERGTYY FFDCLNWRKV AKEFHLEYDK LEERPHLPST FNYNPAQQAFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CNOT2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 74 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 74 nTPM
- cerebellum: 59 nTPM
- skin: 48 nTPM
- thymus: 47 nTPM
- retina: 43 nTPM
- tonsil: 40 nTPM
Single-cell type
- nk-cells: 404 nCPM
- innate lymphoid cells: 374 nCPM
- pdcs: 341 nCPM
- somatotrophs: 298 nCPM
- neutrophils: 279 nCPM
- microglia: 267 nCPM
Immune cell
- basophil: 92 nTPM
- intermediate monocyte: 70 nTPM
- naive CD8 T-cell: 68 nTPM
- naive CD4 T-cell: 63 nTPM
- NK-cell: 62 nTPM
- myeloid DC: 60 nTPM
Brain region
- cerebellum: 151 nTPM
- white matter: 100 nTPM
- medulla oblongata: 81 nTPM
- thalamus: 81 nTPM
- basal ganglia: 78 nTPM
- pons: 78 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CNOT2.
Disease | AllUniProt
Conditions CNOT2 is implicated in, by any mechanism.
- Intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomalies (IDNADFS) MIM:618608
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 90 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomalies
- Neurodevelopmental disorder
- Inborn genetic diseases
- ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.19
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.65
- DepMap mean gene effect
- -0.49
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of intracellular estrogen receptor signaling pathway
- negative regulation of transcription by RNA polymerase II
- nuclear-transcribed mRNA poly(A) tail shortening
- positive regulation of cytoplasmic mRNA processing body assembly
- regulation of stem cell population maintenance
- regulation of transcription by RNA polymerase II
- regulation of translation
- regulatory ncRNA-mediated gene silencing
- trophectodermal cell differentiation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CNOT2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CNOT2 as an antibody target. Whether an autoantibody or antibody against CNOT2 could matter depends on whether native CNOT2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CNOT2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CNOT2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...